The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Brian N. Finck(Washington University in St. Louis), Daniel P. Kelly(Cardiovascular Institute of the South), Attila Kovács(Cardiovascular Research Center), John J. Lehman, Gary D. Lopaschuk(University of Alberta), Michael J. Welch(Geological Survey of Denmark and Greenland), Richard W. Gross(Washington University in St. Louis), Xianlin Han(The University of Texas at San Antonio Health Science Center), Ray Kozak(University of Alberta), Teresa C. Leone(Cardiovascular Institute of the South), Michael J. Bennett(Children's Hospital of Philadelphia)
Cited by 879
Related Papers
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
|Journal of Clinical Investigation|2006|1.4k
Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
|Journal of Clinical Investigation|2000|1.3k
Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples
|Mass Spectrometry Reviews|2004|1.1k
PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis
|PLoS Biology|2005|942
A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders
|Proceedings of the National Academy of Sciences|1999|940